Oceanside Industrial Project Arriving As Market May Be Reaching Its Limit

Oceanside is running out of room for construction of new industrial projects, and there’s not much room left for companies that want to lease space in existing buildings.

$140M UC San Diego Health Outpatient Pavilion to Debut

On March 12, UC San Diego Health will open the Koman Family Outpatient Pavilion, sporting specialty services for breast, urology, sports medicine and spine care.

Tease photo

Vividion Locks Down $101M Upfront in Celgene Collaboration

The San Diego biotech will receive the payment as part of a four-year collaboration with Celgene.

Poseida Therapeutics Names Mark Gergen as CBO, CFO

Mark J. Gergen has joined San Diego-based Poseida Therapeutics as chief business officer and chief financial officer, bringing 25 years of life sciences experience.

Co.’s Rodent Testing Niche Aims for NASH Treatment

Clients of Carlsbad’s Triangulum Biopharma include the likes of NASA, or National Aeronautics and Space Administration. Yet Triangulum won’t comment on the specific nature of the contract.

Tease photo

Ionis Reports Promising Huntington’s Disease Drug Trial

The Carlsbad drugmaker reported positive early stage data on a potentially groundbreaking drug to reduce the underlying cause of Huntington’s Disease.

Beacon Discovery, Takeda Ink Deal

San Diego’s Beacon Discovery formed a multi-year drug discovery collaboration with Takeda Pharmaceutical Company centered on gastrointestinal disorders.

Okogen Receives $10 Million for Pink Eye Treatment

San Diego’s Okogen received $10 million in Series A funding to advance the company’s lead candidate for viral conjunctivis, commonly known as pink eye.

Ionis Reports Big Gains in Q4, Full 2017 Results

Ionis Pharmaceuticals in Carlsbad Reported $508 million in 2017 revenue, a 46.3 percent increase over the previous year, driven by rising drug royalties.

Oceanside Medical Building Sold

Medical group will remain as tenants.

Tease photo

NuVasive Reports Q4 Results

Spine surgery and medical device maker NuVasive reported revenue of $271.1 million in the fourth quarter for flat year-over-year growth.

Neuroscience May Belong to the Nimble

MEDICINE: Big Players Bail, But Midsize Cos. Aim for Next Big Thing

Amid big pharma’s waning commitment to neurological disorders like Alzheimer’s, San Diego startups and midstage biotechs see opportunity.

Tease photo

UC San Diego Health Selects Model, Launches Its ACO

MEDICINE: System Is Betting On Treatment Strategies Success

UC San Diego Health has launched a Medicare program that brings the potential for health system savings — that is, if it can meet care and cost requirements.

Tease photo

John DeFord to Join NuVasive Board

With DeFord’s appointment, the board will have 10 directors, nine of whom are independent.

Ionis Licenses Kidney Drug in Deal Worth up to $330M

Carlsbad’s Ionis Pharmaceuticals has licensed a kidney drug to British giant AstraZeneca, earning $30 million upfront and the potential for $300 million in development and regulatory milestone payments.